高血壓治療藥的中國市場
市場調查報告書
商品編碼
86341

高血壓治療藥的中國市場

Hypertension Drugs Markets in China

出版日期: | 出版商: Asia Market Information & Development Co. | 英文 215 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

本報告提供中國的高血壓治療藥市場相關調查分析,需求與產業趨勢的預測,及商業環境,提供著市場進入相關的資訊。

目錄

第1章 簡介

  • 調查範圍和調查手法
  • 摘要整理

第2章 商業環境

  • 經濟預測
  • 主要經濟指標
  • 工業生產
  • 人口和勞動力
  • 外國投資
  • 國際貿易
  • 財務和稅金的法規
  • 銀行系統和法規
  • 外匯
  • 稅金和關稅

第3章 高血壓治療藥產業的評估

  • 高血壓治療藥產業結構
  • 市場規模
  • 促進市場成長的要素
  • 高血壓治療藥的銷售量
  • 主要的生產設施的場所
  • 主要生產者的銷售量與市場佔有率
  • 人事費用
  • 潛在的參與企業
  • 主要的銷售商
  • 主要的外國投資
  • 技術開發

第4章 高血壓治療藥的生產和需求

  • 市場概要:醫藥品各分類
  • 鈣離子通道阻斷劑
  • ferojipin
  • Nifedipine
  • amurojipin
  • nisorujipin
  • nimojipin
  • nitorenjipin
  • 血管收縮素II受體拮抗劑
  • 俄蘇丹
  • valsartan
  • Irbesartan
  • Telmisartan
  • kandesarutan
  • 血管收縮素轉化酵素抑制劑
  • benazepuriru
  • enarapuriru
  • kaputopuriru
  • rishinopuriru
  • ramipuriru
  • 其他的高血壓治療藥
  • 進口和出口
  • 按市場概要:生產者
  • 價格趨勢

第5章 高血壓治療藥市場預測

  • 高血壓治療藥市場預測概要
  • 政府的法規
  • 醫療保險產業概要
  • 消費者支出趨勢
  • 東北
  • 東南
  • 中部
  • 西南
  • 西北
  • 人口動態趨勢
  • 醫療產業趨勢
  • 醫院和病床

第6章 行銷策略

  • 中國市場進入概要
  • 中國的流通系統
  • 高血壓治療藥的流通管道
  • 運輸和貨物的基礎設施
  • 通訊
  • 中國市場進入
  • 授權
  • 專利權
  • 電子商務
  • 公司和現場的代理店
  • 代表辦事處和中國的子公司
  • 完全外資企業

第7章 高血壓治療藥生產者名錄

  • 與高血壓治療藥生產者的簡介產業主要的消費
Product Code: 808

China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Hypertension Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Market Overview by Drugs Classification
  • Calcium Channel Blocker
  • Felodipine
  • Nifedipine
  • Amlodipine
  • Nisoldipine
  • Nimodipine
  • Nitrendipine
  • Angiotensin II Receptor Antagonists Drug
  • Losartan
  • Valsartan
  • Irbesartan
  • Telmisartan
  • Candesartan
  • Angiotensin-Converting Enzyme Inhibitor
  • Benazepril
  • Enalapril
  • Captopril
  • Lisinopril
  • Ramipril
  • Other Hypertension Drugs
  • Import and Export
  • Market Overview by Producers
  • Pricing Trend

V. HYPERTENSION DRUGS MARKET OUTLOOK

  • Hypertension Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. HYPERTENSION DRUGS PRODUCER DIRECTORY

  • Profiles of Hypertension Drugs Producers and Major Consumption in Industry

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume
  • Major Producer Facility Location
  • Major Hypertension Drugs Producer Sales Volume
  • Major Foreign Investment in China

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Hypertension Drugs Export by Drugs Classification
  • Hypertension Drugs Major Producer, Sales Volume, and Market Share

V. HYPERTENSION DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds

LIST OF CHARTS

I. INTRODUCTION

  • Hypertension Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS

  • Total Hypertension Drugs Sales Volume
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Market Share by Drugs Classification
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Sales Volume

IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND

  • Hypertension Drugs Sales Volume
  • Hypertension Drugs Import
  • Hypertension Drugs Export
  • Hypertension Drugs Sales Volume by Drugs Classification
  • Calcium Channel Blocker Sales Volume and Market Share
  • Calcium Channel Blocker Market Share by Drugs Classification
  • Angiotensin II Receptor Antagonists Drug Sales Volume and Market Share
  • Angiotensin II Receptor Antagonists Drug Market Share by Drugs Classification
  • Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification
  • Other Hypertension Drugs Sales Volume and Market Share
  • Other Hypertension Drugs Market Share by Drugs Classification
  • Hypertension Drugs Import by Drugs Classification
  • Calcium Channel Blocker Import and Market Share
  • Angiotensin II Receptor Antagonists Drug Import and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Import and Market Share
  • Other Hypertension Drugs Import and Market Share
  • Hypertension Drugs Export by Drugs Classification
  • Calcium Channel Blocker Export and Market Share
  • Angiotensin-Converting Enzyme Inhibitor Export and Market Share
  • Angiotensin II Receptor Antagonists Drug Export and Market Share
  • Other Hypertension Drugs Export and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel